Copy into your RSS Reader
Copy into your Podcast App
Andrew Witty, CEO of GlaxoSmithKline, says that better control of infectious diseases in Africa is allowing chronic diseases to come to the surface.
March 31, 2014 As infectious diseases come under control in Africa, other illnesses common in the West are becoming problems. GlaxoSmithKline is opening a research lab to promote research by African scientists.
July 3, 2012 The government released a slew of documents in the Glaxo settlement that serve as a one-stop guide to sales practices that allegedly ran rampant for years.
GlaxoSmithKline's mishandling of information on safety problems with diabetes drug Avandia is just one of the violations cited in a settlement with the government.
Joe Raedle/Getty Images
July 2, 2012 The British drugmaker has agreed to pay $3 billion and is pleading guilty to criminal charges related to its marketing of two antidepressants and failure to provide the Food and Drug Administration with data about safety problems with the diabetes pill Avandia.
NPR thanks our sponsors
Become an NPR sponsor